RAD 001 (everolimus) prevents mTOR and Akt late re-activation in response to imatinib in chronic myeloid leukemia

Journal of Cellular Biochemistry (2010) - Comment
pubmed: 20014066 doi: 10.1002/jcb.22380 issn: 1097-4644 issn: 0730-2312

Manuela Mancini, Sara Petta, Giovanni Martinelli, Enza Barbieri, Maria A. Santucci